Nrf2, a novel molecular target to reduce type 1 diabetes associated secondary complications: The basic considerations
| Autor: | Negi, Chander K., Jena, Gopabandhu |
|---|---|
| Zdroj: | In European Journal of Pharmacology 15 January 2019 843:12-26 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect